Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02997163
Title An Open-Label Pharmacokinetics and Safety Study of Talazoparib
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

Advanced Solid Tumor

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46804 United States Details
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46845 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Karmanos Cancer Institute Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Robert Wood Johnson University Hospital New Brunswick New Jersey 08901 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Juravinski Cancer Centre Hamilton Ontario L8V 5C2 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field